FDA-AACR Workshop to Address Multiple Myeloma Clinical Trial Disparities
By Trevan Locke, PhD Thanks to a wave of newly approved therapies in the past two decades, survival rates...
Category: AACR
By Trevan Locke, PhD Thanks to a wave of newly approved therapies in the past two decades, survival rates...
Despite considerable progress against cancer, the disease continues to take a huge toll on global health. Each year, approximately...
The new year began with the good news that death rates from cancer are continuing their steady decline. A...
Around 400 BC, the Greek physician Hippocrates is believed to have first described tumors as “cancer,” using the words...
In 2019, research continued to drive progress across the spectrum of cancer care in the form of new and...
Earlier this year, the American Association of Cancer Research (AACR) partnered with Novocure, a global oncology company, to launch...
As October comes to a close, it’s time for our latest edition of Editors’ Picks. This monthly staple is...
As Greek mythology tells us, the titan Prometheus was punished by the gods for giving fire to man. His...
Breast cancer can be a scary diagnosis. Even though mortality rates have declined in recent years in the United...
Providing a forum for innovative cancer researchers around the world, Singapore will hold its 11th Frontiers in Cancer Science...